HomeQuestion

Do you ever initiate daptomycin plus an anti-MRSA cephalosporin as upfront combination therapy in a patient with MRSA bacteremia and an endovascular source?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

In what situations would you treat a corynebacterium positive blood culture as a true pathogen compared to a contaminant?

For a patient on appropriate treatment for invasive aspergillosis, how do you determine if and when it is acceptable to reintroduce a TNF inhibitor that likely contributed to their acquisition of the infection but is considered essential for control of their inflammatory condition?

How do you or your practice manage young, average-risk patients without structural lung disease referred to you or self-referred for concern of environmental mold exposure?

How long do you treat uncomplicated streptococcal bacteremia?

In what clinical scenarios would you use amoxacillin over amoxacillin-clavulanate for acute bacterial sinusitis?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.